X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (33) 33
humans (31) 31
male (22) 22
middle aged (20) 20
oncology (20) 20
female (19) 19
adult (16) 16
aged (16) 16
radiotherapy (13) 13
radiology, nuclear medicine & medical imaging (10) 10
cancer (8) 8
head and neck neoplasms - radiotherapy (7) 7
irradiation (7) 7
treatment outcome (7) 7
prognosis (6) 6
radiotherapy dosage (6) 6
carcinoma (5) 5
care and treatment (5) 5
chemotherapy (5) 5
hematology, oncology and palliative medicine (5) 5
radiation-therapy (5) 5
therapy (5) 5
aged, 80 and over (4) 4
animals (4) 4
dose fractionation (4) 4
head (4) 4
neoplasm staging (4) 4
prospective studies (4) 4
prostate cancer (4) 4
radiation (4) 4
radiation injuries - prevention & control (4) 4
surgery (4) 4
survival (4) 4
toxicity (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
boron neutron capture therapy (3) 3
boron neutron capture therapy - methods (3) 3
boronophenylalanine (3) 3
carcinoembryonic antigen - blood (3) 3
carcinoma, squamous cell - radiotherapy (3) 3
combined modality therapy (3) 3
disease-free survival (3) 3
dna, neoplasm - analysis (3) 3
feasibility studies (3) 3
flow cytometry (3) 3
head and neck cancer (3) 3
intensity modulated radiotherapy (3) 3
neck-cancer (3) 3
pain (3) 3
ploidies (3) 3
prostatic neoplasms - radiotherapy (3) 3
radiology (3) 3
radiology and nuclear medicine (3) 3
radiotherapy, conformal - methods (3) 3
rectal neoplasms - pathology (3) 3
squamous-cell carcinoma (3) 3
survival analysis (3) 3
survival rate (3) 3
xerostomia (3) 3
aneuploidy (2) 2
antigens, tumor-associated, carbohydrate - blood (2) 2
biomarkers, tumor - analysis (2) 2
bnct (2) 2
boron (2) 2
boron compounds - therapeutic use (2) 2
boron neutron capture therapy - adverse effects (2) 2
brain neoplasms - radiotherapy (2) 2
brain neoplasms - secondary (2) 2
carcinoembryonic antigen (2) 2
carcinoma - radiotherapy (2) 2
carcinomas (2) 2
cell lung-cancer (2) 2
clinical trials (2) 2
clinical-trials (2) 2
colonic neoplasms - genetics (2) 2
colonic neoplasms - pathology (2) 2
colorectal carcinomas (2) 2
colorectal neoplasms - drug therapy (2) 2
colorectal neoplasms - genetics (2) 2
colorectal neoplasms - pathology (2) 2
conformal radiotherapy (2) 2
diagnostic imaging (2) 2
diploidy (2) 2
disease progression (2) 2
diseases (2) 2
dose escalation (2) 2
dose-response relationship, radiation (2) 2
drug administration schedule (2) 2
epirubicin - administration & dosage (2) 2
fatigue (2) 2
flow-cytometry (2) 2
fluorouracil - administration & dosage (2) 2
follow-up studies (2) 2
fructose (2) 2
fructose - analogs & derivatives (2) 2
gender (2) 2
gm-csf (2) 2
head and neck neoplasms - mortality (2) 2
head and neck neoplasms - pathology (2) 2
head-and-neck cancer (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2007, Volume 69, Issue 2, pp. 475 - 482
Journal Article
Cancer Research, ISSN 0008-5472, 06/2010, Volume 70, Issue 11, pp. 4297 - 4309
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 1, pp. e67 - e75
Purpose To investigate the efficacy and safety of boron neutron capture therapy (BNCT) in the treatment of inoperable head-and-neck cancers that recur locally... 
Radiology | Hematology, Oncology and Palliative Medicine | Head-and-neck cancer | Radiotherapy | Boronophenylalanine | Boron neutron capture therapy | Neoplasm Recurrence, Local - radiotherapy | Confidence Intervals | Prospective Studies | Phenylalanine - analogs & derivatives | Humans | Middle Aged | Fatigue - etiology | Boron Neutron Capture Therapy - adverse effects | Male | Carcinoma, Squamous Cell - radiotherapy | Neoplasm Recurrence, Local - mortality | Osteoradionecrosis - etiology | Carcinoma, Squamous Cell - mortality | Pain - etiology | Adult | Female | Phenylalanine - therapeutic use | Sarcoma - radiotherapy | Radiotherapy Dosage | Boron Neutron Capture Therapy - methods | Disease-Free Survival | Head and Neck Neoplasms - radiotherapy | Mouth Diseases - etiology | Carcinoma, Adenoid Cystic - mortality | Mucositis - etiology | Aged | Carcinoma, Adenoid Cystic - radiotherapy | Head and Neck Neoplasms - mortality | Xerostomia - etiology | Boron Compounds - therapeutic use | Clinical trials | Care and treatment | Boron-neutron capture therapy | Nuclear radiation | Cancer | Index Medicus | SURGERY | HEAD | PATIENTS | BORON | SAFETY | FATIGUE | OSTEORADIONECROSIS | PHOTONS | NEUTRON CAPTURE THERAPY | EVALUATION | RADIATION DOSES | TOXICITY | CHEMOTHERAPY | IRRADIATION | FRUCTOSE | PAIN | SURVIVAL TIME | SARCOMAS | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | NECK
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 78, Issue 1, pp. 42 - 49
Purpose To estimate the safety and tolerability of daily administration of 250 mg of gefitinib given concurrently with three-dimensional conformal radiotherapy... 
Radiology | Hematology, Oncology and Palliative Medicine | Chemotherapy | EGFR targeted therapy | Nonmetastatic prostate cancer | Gefitinib | Radiotherapy | GROWTH-FACTOR-RECEPTOR | PROTEIN-KINASE | DNA-DAMAGE | II TRIAL | RADIATION | CELL LUNG-CANCER | INDUCED PROLIFERATION | ONCOLOGY | TYROSINE KINASE INHIBITOR | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SQUAMOUS CARCINOMA-CELLS | ZD1839 | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - radiotherapy | Humans | Middle Aged | Tumor Necrosis Factor-alpha - blood | Male | Antineoplastic Agents - administration & dosage | Neoplasm Proteins - metabolism | Antineoplastic Agents - adverse effects | Interleukin-6 - blood | Quinazolines - administration & dosage | Prostatic Neoplasms - drug therapy | Radiotherapy Dosage | Prostatic Neoplasms - pathology | Drug Administration Schedule | Receptor, Epidermal Growth Factor - analysis | Combined Modality Therapy - adverse effects | Interleukin-1alpha - blood | Prostate-Specific Antigen - blood | Disease-Free Survival | Maximum Tolerated Dose | Quinazolines - adverse effects | Aged | Combined Modality Therapy - methods | Neoplasm Staging | Cancer patients | Care and treatment | Radiation | Clinical trials | Product development | Prostate cancer | Cancer | Index Medicus | Adjuvants | PROSTATE | NEOPLASMS | MALE GENITALS | ANTIGENS | ANTINEOPLASTIC DRUGS | THREE-DIMENSIONAL CALCULATIONS | MEDICINE | CHEMOTHERAPY | NUCLEAR MEDICINE | ORGANS | DISEASES | THERAPY | GLANDS | DRUGS | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | BODY | RADIOLOGY
Journal Article
Clinical Endocrinology, ISSN 0300-0664, 2010, Volume 73, Issue 1, pp. 72 - 77
To investigate the long-term outcome of fractionated stereotactic radiotherapy (FSRT) [45 Gy (range 45-54) in 25 fractions] in patients with pituitary adenomas... 
Medical research | Care and treatment | Brain tumors | Patient outcomes | Medicine, Experimental | Development and progression | Radiotherapy
Journal Article
European Urology, ISSN 0302-2838, 07/2019
BACKGROUNDIt remains unclear whether patients with positive surgical margins or extracapsular extension benefit from adjuvant radiotherapy following radical... 
Index Medicus
Journal Article
Strahlentherapie und Onkologie, ISSN 0179-7158, 11/2015, Volume 191, Issue 11, p. 862
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00066-015-0868-5 To... 
CT imaging | Diagnostic imaging | Radiotherapy | Prostate cancer
Journal Article
Journal Article